Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2229.65 -18.25 (-0.81%) | NSE 2230.70 -18.80 (-0.84%) | Trade | Add

BSE Live

Apr 20, 16:01

2229.65 -18.25 (-0.81%)

Volume

AVERAGE VOLUME

5-Day

21,561

10-Day

32,872

30-Day

28,786

14,742

Prev. Close

2247.90
Open Price

2259.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 20, 15:56

2230.70 -18.80 (-0.84%)

Volume

AVERAGE VOLUME

5-Day

562,078

10-Day

590,809

30-Day

649,460

407,547

Prev. Close

2249.50
Open Price

2249.50

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2230.70 (26)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Glenmark Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	13,145.84	11,813.10	12,725.43	12,174.20	10,806.03
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	13,145.84	11,813.10	12,725.43	12,174.20	10,806.03
Total Operating Revenues	13,321.74	11,813.10	12,990.11	12,304.90	10,943.93
Other Income	113.72	839.99	316.79	166.67	50.22
Total Revenue	13,435.46	12,653.09	13,306.90	12,471.58	10,994.15
EXPENSES
Cost Of Materials Consumed	3,001.27	3,157.82	3,593.79	3,278.76	3,137.81
Purchase Of Stock-In Trade	1,566.00	1,451.17	1,268.26	1,117.67	750.27
Operating And Direct Expenses	89.54	0.00	0.00	74.42	44.99
Changes In Inventories Of FGWIP And Stock In Trade	-213.93	-195.62	-325.09	-11.14	-189.25
Employee Benefit Expenses	3,022.06	2,868.14	2,780.96	2,447.42	2,343.71
Finance Costs	207.07	515.97	349.58	298.10	353.11
Depreciation And Amortisation Expenses	486.01	581.91	611.27	486.72	443.55
Other Expenses	3,505.42	3,336.25	3,393.83	3,077.48	2,772.03
Total Expenses	11,663.43	11,715.64	11,672.59	10,769.42	9,656.22
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,772.03	937.45	1,634.31	1,702.16	1,337.93
Exceptional Items	-372.82	-900.96	-765.85	-260.91	44.55
Profit/Loss Before Tax	1,399.21	36.50	868.45	1,441.25	1,382.48
Tax Expenses-Continued Operations
Current Tax	382.34	1,115.55	566.90	546.65	498.14
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-30.27	751.79	-75.85	-99.05	-85.75
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	352.07	1,867.35	491.05	447.60	412.39
Profit/Loss After Tax And Before ExtraOrdinary Items	1,047.14	-1,830.85	377.40	993.65	970.09
Profit/Loss From Continuing Operations	1,047.14	-1,830.85	377.40	993.65	970.09
Profit/Loss For The Period	1,047.14	-1,433.52	377.40	993.65	970.09
Minority Interest	-0.05	-68.15	-80.16	-51.94	-0.05
Consolidated Profit/Loss After MI And Associates	1,047.10	-1,501.67	297.25	941.71	970.04
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	37.00	-53.00	11.00	33.00	34.00
Diluted EPS (Rs.)	37.00	-53.00	11.00	33.00	34.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	70.55	70.54	70.54	70.54	70.54
Tax On Dividend	0.00	0.00	0.00	0.00	0.00